Friday, September 11, 2020 3:29:51 PM
I didn't discount they aren't looking at safety because I can guarantee you they are. It's the FDA and they've never run trials in the US that I am aware of.
This stock had the same late day run-up last Friday about the same time. Maybe it's shorts covering for the weekend... Or just people that want to buy in case news hits in Switzerland before the market opens Monday.
PS: I'm enjoying your chart analysis but when we get FDA EUA there won't be a chart that tells us where we're going.
This stock had the same late day run-up last Friday about the same time. Maybe it's shorts covering for the weekend... Or just people that want to buy in case news hits in Switzerland before the market opens Monday.
PS: I'm enjoying your chart analysis but when we get FDA EUA there won't be a chart that tells us where we're going.
$RLFTF & $HGEN
- The two leading therapeutics in the fight against Covid-19
Recent RLFTF News
- MindMaze Therapeutics Announces Initiation of Coverage by Baader Bank • ACCESS Newswire • 03/19/2026 06:35:00 AM
- MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics • ACCESS Newswire • 12/23/2025 06:20:00 AM
- Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics • ACCESS Newswire • 12/15/2025 06:20:00 AM
- Relief Therapeutics Shareholders Approve Business Combination with NeuroX • ACCESS Newswire • 11/14/2025 05:40:00 PM
- Relief Therapeutics Announces Positive Results from Pivotal Bioequivalence Study of RLF-OD032 • ACCESS Newswire • 10/29/2025 06:20:00 AM
- Micro-Cap Biotech Skyrockets on FDA Pediatric Disease Nod • AllPennyStocks.com • 05/22/2025 04:49:00 PM
